Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127146641 | 12714664 | 1 | I | 20160202 | 20160829 | 20160905 | 20160905 | EXP | GB-ASTRAZENECA-2016SE92334 | ASTRAZENECA | 72.00 | YR | Y | 0.00000 | 20160905 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127146641 | 12714664 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 19810 | ||||||||||
| 127146641 | 12714664 | 2 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | U | U | 0 | |||||||||
| 127146641 | 12714664 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 300.0MG UNKNOWN | 0 | 300 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127146641 | 12714664 | 2 | Transient ischaemic attack |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127146641 | 12714664 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127146641 | 12714664 | Facial paralysis | |
| 127146641 | 12714664 | Labelled drug-drug interaction medication error | |
| 127146641 | 12714664 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127146641 | 12714664 | 2 | 201412 | 0 |